KDOQI (Kidney Disease Outcomes Quality Initiative)


Executive Summaries of 2000 Updates | Anemia | Hemodialysis | Peritoneal Dialysis
Vascular Access | Nutrition | Chronic Kidney Disease | History of DOQI


KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification


1. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32:992-999, 1998 (erratum 35:178, 2000)

2. US Renal Data System. USRDS 1998 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 1998

3. Sarnak MJ, Levey AS: Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 35:S117-S131, 2000 (suppl 1)

4. US Renal Data System. USRDS 2000 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2000

5. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161:1207-1216, 2001

6. Keane WF, Eknoyan G: Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 33:1004-1010, 1999

7. Hogg RJ, Portmann RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J: Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on Proteinuria, Risk, Assessment, Detection, Elimination (PARADE). Pediatrics 105:1242-1249, 2000

8. American Diabetes Association: Clinical Practice  Recommendations 2001. Diabetes Care 24:S69-S72, 2001 (suppl 1)

9. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske RL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Disease 32:853-905, 1998

10. McClellan WM, Knight DF, Karp H, Brown WW: Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines. Am J Kidney Dis 29:368-375, 1997

11. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ: Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10:1793-1800, 1999

12. Kannel WB, Stampfer MJ, Castelli WP, Verter J: The prognostic significance of proteinuria: The Framingham study. Am Heart J 108:1347-1352, 1984

13. Iseki K, Iseki C, Ikemiya Y, Fukiyama K: Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49:800-805, 1996

14. Perneger TV, Brancati FL, Whelton PK, Klag MJ: Studying the causes of kidney disease in humans: A review of methodologic obstacles and possible solutions. Am J Kidney Dis 25:722-731, 1995

15. Pereira KI: Optimization of pre-ESRD care: The key to improved dialysis outcomes. Kidney Int 57:351-365, 2000

16. NKF-KDOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000. Am J Kidney Dis 37:S65-S136, 2001 (suppl 1)

17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999

18. Levey AS, Greene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11:A0828, 2000 (abstr)

19. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7:930-937, 1996

20. Barratt TM, McLaine PN, Soothill JF: Albumin excretion as a measure of glomerular dysfunction in children. Arch Dis Child 45:496-501, 1970

21. Davies AG, Postlethwaite RJ, Price DA, Burn JL, Houlton CA, Fielding BA: Urinary albumin excretion on school children. Arch Dis Child 59:625-630, 1984

22. Bangstad HJ, Dahl-Jorgensen K, Kjaersgaard P, Mevold K, Hanssen KF: Urinary albumin excretion rate and puberty in non-diabetic children and adolescents. Acta Paediatr 82:857-862, 1993

23. Cowell CT, Rogers S, Silink M: First morning urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in children with type 1 (insulin-dependent) diabetes. Diabetologia 29:97-99, 1986

24. Salardi S, Cacciari, Pascucci MG, Giambiasi E, Tacconi M, Tazzari R: Microalbuminuria in diabetic children and adolescents. Relationship with puberty and growth hormone. Acta Paediatr Scand 79:437-433, 1990

25. Marshall SM, Hackett A, Court S, Parkin M, Alberti KG: Albumin excretion in children and adolescents with insulin-dependent diabetes. Diabetes Res 3:345-348, 1986

26. Ellis D, Buffone GJ: New approach to evaluation of proteinuric states. Clin Chem 23:666-670, 1977

27. Mathiesen ERS, Saurbrey N, Hommel E, Parving HH: Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29:640-633, 1986

28. Brøchner-Mortensen J, Ditzel J, Mogensen CE, Rodbro P: Microvascular permeability to albumin and glomerular filtration rate in diabetic and normal children. Diabetologia 16:307-311, 1979

29. Mortensen HB, Marinelli K, Norgaard K, Main K, Kastrup KW, Ibsen KK, Villumsen J, Parving HH: A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 10:887-977, 1990

30. Dahlquist G, Rudberg S: The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand 76:795-8000, 1987

31. Erman A, van Dyk DJ, Rabinov M, Boner G, Rosenfeld JB: Urinary albumin excretion in the healthy population. Isr J Med Sci 26:389-392, 1990

32. Holl RW, Grabert M, Thon A, Heinze E: Urinary excretion of albumin in adolescents with type 1 diabetes: Persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care 22:1555-1560, 1999

33. Huttunen NP, Kaar M, Puukka R, Akerblom HK: Exercise-induced proteinuria in children and adolescents with type 1 (insulin dependent) diabetes. Diabetologia 21:495-497, 1981

34. Chiumello G, Bognetti E, Meschi F, Carra M, Balzano E: Early diagnosis of subclinical complications in insulin dependent diabetic children and adolescents. J Endocrinol Invest 12:101-104, 1989 (suppl 3)

35. Laborde K, Levy-Marchal C, Kindermans C, Dechaux M, Czernichow P, Sachs C: Glomerular function and microalbuminuria in children with insulin-dependent diabetes. Pediatr Nephrol 4:39-433, 1990

36. Mullis P, Kochli HP, Zuppinger K, Schwarz HP: Intermittent microalbuminuria in children with type 1 diabetes mellitus without clinical evidence of nephropathy. Eur J Pediatr 147:385-388, 1988

37. Elises JS, Griffiths PD, Hocking MD, Taylor CM, White RH: Simplified quantification of urinary protein excretion in children. Clin Nephrol 30:225-229, 1988

38. Ginevri F, Piccotti E, Alinovi R, DeToni T, Biagini C, Chiggeri GM, Gusmano R: Reversible tubular proteinuria precedes microalbuminuria and correlates with the metabolic status of diabetic children. Pediatr Nephrol 7:23-26, 1993

39. Houser MT: Characterization of proteinuria using random urine samples. Int J Pediatr Nephrol 7:197-202, 1986

40. Hjorth L, Helin I, Grubb A: Age-related reference limits for urine levels of albumin, orosomucoid, immunoglobulin G and protein HC in children. Scand J Clin Lab Invest 60:65-73, 2000

41. Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB: Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 22:495-502, 1999

42. Gibb D, Shah V, Preece M, Barratt TM: Variability of urine albumin excretion in normal and diabetic children. Pediatr Nephrol 3:414-419, 1989

43. Schultz CJ, Dalton RN, Turner C, Neil HA, Dunger DB: Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group. Diabet Med 17:7-14, 2000

44. Yap C, Yap HK, Chio LF: Urine microalbumin/creatinine ratios in Singapore children. J Singapore Paediatr Soc 33:101-106, 1991

45. Jefferson IG, Greene SA, Smith MA, Smith RF, Griffin NKG, Baum JD: Urine albumin to creatinine ratio-response to exercise in diabetes. Arch Dis Child 60:305-310, 1985

46. Cesarini PR, Ferreira SR, Vivolo MA, Zanella MT: Different urinary albumin responses to submaximal exercise by normoalbuminuric diabetic children and controls. Brazilian J Med Biol Res 29:1603-1610, 1996

47. Murakami M, Yamamoto H, Ueda Y, Murakami K, Yamauchi K: Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo. Pediatr Nephrol 5:50-53, 1991

48. Lin CY, Sheng CC, Chen CH, Lin CC, Chou P: The prevalence of heavy proteinuria and progression risk factors in children undergoing urinary screening. Pediatr Nephrol 14:953-959, 2000

49. Vehaskari VM, Rapola J: Isolated proteinuria: Analysis of a school-age population. J Pediatr 101:661-688, 1982

50. Wagner MG, Smith FG Jr, Tinglof BO Jr, Cornberg E: Epidemiology of proteinuria. A study of 4,807 schoolchildren. J Pediatr 73:825-832, 1968

51. Randolph MF, Greenfield M: Proteinuria. A six-year study of normal infants, preschool, and school-age populations previously screened for urinary tract disease. Am J Dis Child 114:631-638, 1967

52. Johnson A, Heap GJ, Hurley BP: A survey of bacteriuria, proteinuria and glycosuria in five-year-old schoolchildren in canberra. Med J Aust 2:122-124, 1974

53. Wolman IJ: The incidence, causes and intermittency of proteinuria in young men. Am J Med Sci 210:86-100, 1945

54. Kunin CM, Deutscher R, Paquin A Jr: Urinary tract infection in school children: An epidemiologic, clinical and laboratory study. Medicine (Baltimore) 43:91-130, 1964

55. Meadow SR, White RH, Johnston NM: Prevalence of symptomless urinary tract disease in Birmingham schoolchildren. I. Pyuria and bacteriuria. BMJ 3:81-84, 1969

56. Mitchell N, Stapleton FB: Routine admission urinalysis examination in pediatric patients: A poor value. Pediatrics 86:345-349, 1990

57. Hamill SM, Blackfan KD: Frequency and significance of albumin in the urines of normal children. Am J Dis Child 1:139-163, 1911

58. Dodge WF, West EF, Smith EH, Bruce H III: Proteinuria and hematuria in schoolchildren: Epidemiology and early natural history. J Pediatr 88:327-347, 1976

59. Hogg RJ, Harris S, Lawrence DM, Henning PH, Wigg N, Jureidini KF: Renal tract abnormalities detected in Australian preschool children. J Paediatr Child Health 34:420-424, 1998

60. Silverberg DS: City-wide screening for urinary abnormalities in schoolboys. Can Med Assoc J 7:410-422, 1974

61. Silverberg DS, Allard MJ, Ulan RA, Beamish WE, Lentle BC, McPhee MS, Grace MG: City-wide screening for urinary abnormalities in schoolgirls. Can Med Assoc J 109:981-985, 1973

62. Bashford HH: Adolescent albuminuria: Incidence, significance, and after-history. Lancet 2:1305-1307, 1926

63. Mueller PW, Caudill SP: Urinary albumin excretion in children: Factors related to elevated excretion in the United States population. Ren Fail 21:293-302, 1999

64. Pugia MJ, Lott JA, Kajima J, Saambe T, Sasaki M, Kuromoto K, Nakamura R, Fusegawa H, Ohta Y: Screening school children for albuminuria, proteinuria and occult blood with dipsticks. Clin Chem Lab Med 37:149-157, 1999

65. Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M, Kile E, Walker KA, Wang Z: The multidimensional nature of renal disease: Rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 54:1296-1304, 1998

66. Bernard A, Stolte H, De Broe ME, Mueller PW, Mason H, Lash LH, Fowler BA: Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. IV. Current information on interpreting the health implications of tests. Ren Fail 19:553-566, 1997

67. Smith HW: Comparative physiology of the kidney, in Smith HW (ed): The Kidney: Structure and Function in Health and Disease. New York, NY, Oxford University Press, 1951, pp 520-574

68. Atiyeh BA, Dabbagh SS, Gruskin AB: Evaluation of renal function during childhood. Pediatr Rev 17:175-179, 1996

69. Heilbron DC, Holliday MA, Al-Dahwi A, Kogan BA: Expressing glomerular filtration rate in children. Pediatr Nephrol 5:5-11, 1991

70. Coulthard MG: Maturation of glomerular filtratior in preterm and mature babies. Early Hum Dev 11:281-292, 1985

71. Schwartz GJ, Feld LG, Langford DJ: A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 104:849-854, 1984

72. Davies DF, Shock NW: Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29:496-507, 1950

73. Wesson LG: Physiology of the Human Kidney. New York, Grune and Stratton, 1969

74. Watkins DM, Shock NW: Age-wise standard value for Cin, CPAH, and TmPAH in adult males. J Clin Invest 34:969, 1955

75. NKF-KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis 35:S1-S140, 2000 (suppl 2)

76. Levey AS, Greene T, Burkart J: Comprehensive assessment of the level of renal function at the initiation of dialysis in the MDRD study. J Am Soc Nephrology 9:153A, 1998 (abstr)

77. Obrador GT, Arora P, Kausz AT, Ruthazer R, Pereira BJ, Levey AS: Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population. Kidney Int 56:2227-2235, 1999

78. Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, Pereira BJ: Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10:1281-1286, 1999

79. Jungers P, Zingraff J, Albouze G, Chauveau P, Page B, Hannedouche T, Man NK: Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 8:1089-1093, 1993

80. Sesso R, Yoshihiro MM: Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant 12:2111-2116, 1997

81. Fink JC, Burdick RA, Kurth SJ, Blahut SA, Armistead NC, Turner MS, Shickle LM, Light PD: Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 34:694-701, 1999

82. Iofel Y, Dawood M, Valcourt JS, Ifudu O: Initiation of dialysis is not delayed in whites with progressive renal failure. ASAIO J 44:M598-M600, 1998

83. Ifudu O, Dawood M, Homel P, Friedman EA: Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 28:841-845, 1996

84. Guidance for Industry Pharmacokinetics in Patients with Impaired Renal Function: Study Design, Data Analysis and Impact on Dosing and Labeling. Washington, DC, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, 1998

85. German PS: Compliance with chronic disease. Hypertension 11:1156-1160, 1988

86. Frazier PA, Davis-Ali SH, Dahl KE: Correlates of noncompliance among renal transplant recipients. Clin Transplant 8:550-557, 1994

87. Kiley DJ, Lam CS, Pollack R: A study of treatment compliance following kidney transplantation. Transplantation 55:51-56, 1993

88. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med :2101-2107, 2000

89. Schneider MS, Friend R, Whitaker P, Wadhwa NK: Fluid noncompliance and symptomatology in end-stage renal disease: Cognitive and emotional variables. Health Psychol 10:209-215, 1991

90. Shaw E, Anderson JG, Maloney M, Jay SJ, Fagan D: Factors associated with noncompliance of patients taking antihypertensive medications. Hospital Pharm 30:201-203, 1995

91. McLane CG, Zyzanski SJ, Flocke SA: Factors associated with medication noncompliance in rural elderly hypertensive patients. Am J Hypertens 8:206-209, 1995

92. Christensen AJ, Smith TW, Turner CW, Holman JM, Gregory MC, Rich MA: Family support, physical impairment, and adherence in hemodialysis: An investigation of main and buffering effects. J Behav Med 15:313-325, 1992

93. Billups SJ, Malone DC, Carter BL: The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 20:941-949, 2000

94. McGrath JM: Physicians’ perspectives on communicating prescription drug information. Qual Health Res 9:731-745, 1999

95. Dusing R, Weisser B, Mengden T, Vetter H: Changes in antihypertensive therapy: The role of adverse effects and compliance. Blood Press 7:313-315, 1998

96. Johnson MJ, Williams M, Marshall ES: Adherent and nonadherent medication-taking in elderly antihypertensive patients. Clin Nurs Res 8:318-335, 1999

97. Sharkness CM, Snow DA: The patient’s view of hypertension and compliance. Am J Prev Med 8:141-146, 1992

98. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J: Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age, gender, and race. Am J Public Health 86:1805-1808, 1996

99. Wright SJ: “Non-compliance”: Meaningful construct or destructive, sticky, stigmatizing label? Edtna Erca J 24:35-38, 1998

100. 27th Bethesda Conference. Matching the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events. September 14-15, 1995. J Am Coll Cardiol 27:957-1047, 1996

101. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyet H-M, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524, 1998

102. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population. Hypertension 25:305-313, 1995

103. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse ST, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778-799, 1998

104. US Renal Data System. Excerpts from the 2000 US Renal Data System Annual Data Report: Atlas of End Stage Renal Disease in the United States. Am J Kidney Dis 36:S1-S279, 2000 (suppl 2)

105. Profiles of General Demographic Characteristics: 2000 Census of Population and Housing, United States. Washington, DC, US Government Printing Office, 2001

106. Day JC: Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. Washington, DC, US Government Printing Office, 1996

107. Elixhauser A, Klemstine K, Steiner C, Bierman A: Procedures in U.S. Hospitals, 1997. Vol. HCUP Fact Book No. 2. Rockville, MD, Agency for Healthcare Resarch and Quality, 2001

108. HCUPnet: Healthcare Cost and Utilization Project. Website: www.ahrq.gov/data/hcup/hcupnet.htm, 7/4

109. McGoldrick MD, Bailie GR: Nonnarcotic analgesics: Prevalence and estimated economic impact of toxicities. Ann Pharmacother 31:221-227, 1997

110. Fries JF: NSAID gastropathy: The second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 18:6-10, 1991

111. Rose BD: Chapter 3: Renal Circulation and Glomerular Filtration Rate: Clinical Physiology of Acid-Base and Electrolyte Disorders. New York, NY, McGraw Hill, 1984

112. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278-285, 1985

113. Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 38:1933-1953, 1992

114. Perrone RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioscopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DPTA, and inulin. The Modification of Diet in Renal Diseases Study. Am J Kidney Dis 16:224-235, 1990

115. Wilson DM, Bergert JH, Larson TS, Liedtke RR: GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis 30:646-652, 1997

116. Deinum J, Derkx FH: Cystatin for estimation of glomerular filtration rate? Lancet 356:1624-1625, 2000

117. Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830-838, 1985

118. Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 39:465-490, 1988

119. Levey AS: Assessing the effectiveness of therapy to prevent progression of renal disease. Am J Kidney Dis 22:207-214, 1993

120. Gault MH, Longerich LL, Harnett JD, Wesolowski C: Predicting glomerular function from adjusted serum creatinine. Nephron 62:249-256, 1992

121. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976

122. Jelliffe RW: Estimation of creatinine clearance when urine cannot be collected. Lancet 1:975-976, 1971

123. Schwartz GJ, Gauthier B: A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522-526, 1985

124. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263, 1976

125. Brion LP, Boeck MA, Gauthier B, Nussbaum MP, Schwartz GJ: Estimation of glomerular filtration rate in anorectic adolescents. Pediatr Nephrol 3:16-21, 1989

126. Brion LP, Fleischman AR, McCarton C, Schwartz GJ: A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: Noninvasive assessment of body composition and growth. J Pediatr 109:698-707, 1986

127. Counahan R, Chantler C, Ghazali S, Kirkwood B, Rose F, Barratt TM: Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 51:875-878, 1976

128. Barratt TM, Chantler C, Lederman S, Rigden SP: Assessment of renal function. Am J Kidney Dis 7:347-349, 1986

129. Morris MC, Allanby CW, Toseland P, Haycock GB, Chantler C: Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 57:611-615, 1982

130. Jelliffe RW: Letter: Creatinine clearance: Bedside estimate. Ann Intern Med 79:604-605, 1973

131. Mawer GE, Lucas SB, Knowles BR, Stirland RM: Computer-assisted prescribing of kanamycin for patients with renal insufficiency. Lancet 1:12-15, 1972

132. Hull JH, Hak LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM: Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Therapeutics 29:516-521, 1981

133. Gates GF: Creatinine clearance estimation from serum creatinine values: An analysis of three mathematical models of glomerular function. Am J Kidney Dis 5:199-205, 1985

134. Bjornsson TD, Cocchetto DM, McGowan FX, Verghese CP, Sedor F: Nomogram for estimating creatinine clearance. Clin Pharmacokinet 8:365-369, 1983

135. Toto RD, Kirk KA, Coresh J, Jones C, Appel L, Wright J, Campese V, Olutade B, Agodoa L: Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: Results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. J Am Soc Nephrol 8:279-287, 1997

136. Agarwal R, Nicar M: A comparative analysis of formulas used to predict creatinine clearance. J Am Soc Nephrol 5:386, 1994

137. Davis GA, Chandler MH: Comparison of creatinine clearance estimation methods in patients with trauma. Am J Health Syst Pharm 53:1028-1032, 1996

138. Edwards KDG, Whyte HM: Plasma creatinine level and creatinine clearance as a test of renal function. Aust Ann Med 8:218-224, 1959

139. Hallynck T, Soep HH, Thomis J, Boelaert J, Daneels R, Fillastre JP, De Rosa F, Rubinstein E, Hatala M, Spousta J, Dettli L: Prediction of creatinine clearance from serum creatinine concentration based on lean body mass. Clin Pharmacol Therapeutics 30:414-421, 1981

140. Mogensen CE, Heilskov NS: Prediction of GFR from serum creatinine. Acta Endocrinol (Copenh) Suppl 238:109, 1980

141. Nankivell BJ, Allen RDM, O’Connell PJ, Chapman JR: Erythrocytes after renal transplantation: Risk factors and relationship with GFR. Clin Transplant 9:375-382, 1995

142. Robinson BA, Frampton CM, Colls BM, Atkinson CH, Fitzharris BM: Comparison of methods of assessment of renal function in patients with cancer treated with cisplatin, carboplatin or methotrexate. Aust NZ J Med 20:657-662, 1990

143. Rowe JWA, Andres R, Tobin JD, Norris AH, Shock NW: The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 31:155-163, 1976

144. Salazar DE, Corcoran GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 84:1053-1060, 1988

145. Sanaka M, Takano K, Shimakura K, Koike Y, Mineshita S: Serum albumin for estimating creatinine clearance in the elderly with muscle atrophy. Nephron 73:137-144, 1996

146. Siersbaek-Nielsen K, Hansen JM, Kampmann J, Kristensen M: Rapid evaluation of creatinine clearance. Lancet 1:1133-1134, 1971

147. Tougaard L, Brochner-Mortensen J: An individual nomogram for determination of glomerular filtration rate from plasma creatinine. Scand J Clin Lab Invest 36:395-397, 1976

148. Yukawa E, Hamachi Y, Higuchi S, Aoyama T: Predictive performance of equations to estimate creatinine clearance from serum creatinine in Japanese patients with congestive heart failure. Am J Ther 6:71-76, 1999

149. Shull BC, Haughley D, Koup JR, Baliah T, Li PK: A useful method for predicting creatinine clearance in children. Clin Chem 24:1167-1199, 1978

150. Traub SL, Johnson CE: Comparison of methods of estimating creatinine clearance in children. Am J Hosp Pharm 37:195-201, 1980

151. Ghazali S, Barratt TM: Urinary excretion of calcium and magnesium in children. Arch Dis Child 49:97-101, 1974

152. Evans GO, Griffiths PD: Limitations concerning the use in children of the relationship between plasma creatinine and body height to derive glomerular filtration rate. Ann Clin Biochem 18:295-298, 1981

153. Hernandez de Acevedo LH, Johnson CE: Estimation of creatinine clearance in children: Comparison of six methods. Clin Pharm 1:158-161, 1982

154. Jelliffe RW, Jelliffe SM: A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex, and weight. Math Biosci 14:17-24, 1972

155. Paap CM, Nahata MC: Prospective evaluation of ten methods for estimating creatinine clearance in children with varying degrees of renal dysfunction. J Clin Pharm Therapeutics 20:67-73, 1995

156. Parkin A, Smith HC, Brocklebank JT: Which routine test for kidney function? Arch Dis Child 64:1261-1263, 1989

157. Rudd GD, Hull JH, Morris CR, Bryan CK: Estimating creatinine clearance in children: Comparison of three methods. Am J Hosp Pharm 37:1514-1517, 1980

158. van den Anker JN, de Groot R, Broerse HM, Sauer PJ, van der Heijden BJ, Hop WC, Lindemans J: Assessment of glomerular filtration rate in preterm infants by serum creatinine: Comparison with inulin clearance. Pediatrics 96:1156-1158, 1995

159. Rolin HA III, Hall PM, Wei R: Inaccuracy of estimated creatinine clearance for prediction of iothalamate glomerular filtration rate. Am J Kidney Dis 4:48-54, 1984

160. Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD: Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis 16:236-243, 1990

161. Charleson HA, Bailey RR, Stewart A: Quick prediction of creatinine clearance without the necessity of urine collection. N Z Med J 92:425-426, 1980

162. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O’Connor D, Ojo A, Phillips R, Sika M, Wright J Jr: African-American Study of Hypertension and Kidney Disease. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 38:744-753, 2001

163. Waller DG, Fleming JS, Ramsey B, Gray J: The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J 67:42-46, 1991

164. DeSanto NG, Coppola S, Anastasio P, Coscarella G, Capasso G, Bellini L, Santangelo R, Massimo L, Siciliano A: Predicted creatinine clearance to assess glomerular filtration rate in chronic renal disease in humans. Am J Nephrol 11:181-185, 1991

165. Bedros F, Kasiske B: Estimating GFR from creatinine clearance in renal transplant recipients. J Am Soc Nephrol 9:666A, 1998 (abstr)

166. Goerdt PJ, Heim-Duthoy KL, Macres M, Swan SK: Predictive performance of renal function estimate equations in renal allografts. Br J Clin Pharmacol 44:261-265, 1997

167. Filler G, Priem F, Vollmer I, Gellermann J, Jung K: Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate. Pediatr Nephrol 13:501-505, 1999

168. Seikaly MG, Browne R, Bajaj G, Arant BS Jr: Limitations to body length/serum creatinine ratio as an estimate of glomerular filtration in children. Pediatr Nephrol 10:709-711, 1996

169. Hellerstein S, Berenbom M, Alon US, Warady BA: Creatinine clearance following cimetidine for estimation of glomerular filtration rate. Pediatr Nephrol 12:49-54, 1998

170. Guignard JP, Torrado A, Feldman H, Gautier E: Assessment of glomerular filtration rate in children. Helv Paediatr Acta 35:437-447, 1980

171. Stake G: Estimation of the glomerular filtration rate in infants and children using iohexol and X-ray fluorescence technique, in Department of Radiology, Section of Paediatric Radiology. Oslo, Norway, University of Oslo, 1992

172. Seikaly MG, Browne R, Simonds N, Atkins C, Alexander SR: Glomerular filtration rate in children following renal transplantation. Pediatr Transplant 2:231-235, 1998

173. Springate JE, Christensen SL, Feld LG: Serum creatinine level and renal function in children. Am J Dis Child 146:1232-1235, 1992

174. Waz WR, Quattrin T, Feld LG: Serum creatinine, height, and weight do not predict glomerular filtration rate in children with IDDM. Diabetes Care 16:1067-1070, 1993

175. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J: Cystatin C—A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101:875-881, 1998

176. Stake G, Monn E, Rootwelt K, Golman K, Monclair T: Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Acta Radiol 30:643-646, 1989

177. Stake G, Monn E, Rootwelt K, Monclair T: The clearance of iohexol as a measure of the glomerular filtration rate in children with chronic renal failure. Scand J Clin Lab Invest 51:729-734, 1991

178. Stake G, Monn E, Rootwelt K, Monclair T: A single plasma sample method for estimation of the glomerular filtration rate in infants and children using iohexol. II: Establishment of the optimal plasma sampling time and a comparison with the 99Tcm-DTPA method. Scand J Clin Lab Invest 51:343-348, 1991

179. Stake G, Monclair T: A single plasma sample method for estimation of the glomerular filtration rate in infants and children using iohexol. I: Establishment of a body weight-related formula for the distribution volume of iohexol. Scand J Clin Lab Invest 51:335-342, 1991

180. Stake G, Monn E, Rootwelt K, Gronberg T, Monclair T: Glomerular filtration rate estimated by X-ray fluorescence technique in children: Comparison between the plasma disappearance of 99Tcm-DTPA and iohexol after urography. Scand J Clin Lab Invest 50:161-167, 1990

181. Walser M: Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 32:23-31, 1998

182. Arant BS Jr, Greifer I, Edelmann CM Jr, Spitzer A: Effect of chronic salt and water loading on the tubular defects of a child with Fanconi syndrome (cystinosis). Pediatrics 58:370-377, 1976

183. Randers E, Erlandsen E: Serum cystatin C as an endogenous marker of the renal function—A review. Clin Chem Lab Med 37:389-395, 1999

184. Holliday MA, Heilborn D, Al-Uzri A, Hidayat J, Uauy R, Conley SB, Reisch J, Hogg RJ: Serial measurements of GFR in infants using the continuous iothalamate infusion technique. Kidney Int 43:893-898, 1993

185. Hellerstein S, Alon US, Warady BA: Creatinine for estimation of glomerular filtration rate. Pediatr Nephrol 6:507-511, 1992

186. Winterborn MH, Beetham R, White RHR: Comparison of plasma disappearance and standard clearance techniques for measuring glomerular filtration rate in children with and without vesico-ureteric reflux. Clin Nephrol 7:262-270, 1977

187. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571-590, 1987

188. Ross JW, Miller WG, Myers GL, Praestgaard J: The accuracy of laboratory measurements in clinical chemistry: A study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods. Arch Pathol Lab Med 122:587-608, 1998

189. Chiou WL, Hsu FH: A new simple and rapid methd to monitor the renal function based on pharmacokinetic consideration of endogenous creatinine. Res Commun Chem Pathol Pharmacol 10:315-330, 1975

190. Kwong MB, Tong TK, Mickell JJ, Chan JC: Lack of evidence that formula-derived creatinine clearance approximates glomerular filtration rate in pediatric intensive care population. Clin Nephrol 24:285-288, 1985

191. Jacobson P, West N, Hutchinson RJ: Predictive ability of creatinine clearance estimate models in pediatric bone marrow transplant patients. Bone Marrow Transplant 19:481-485, 1997

192. Fong J, Johnston S, Valentino T, Notterman D: Length/serum creatinine ratio does not predict measured creatinine clearance in critically ill children. Clin Pharmacol Therapeutics 58:192-197, 1995

193. Gbadegesin RA, Adeyemo AA, Asinobi AO, Osinusi K: Inaccuracy of the Schwartz formula in estimating glomerular filtration rate in Nigerian children. Ann Trop Paediatr 17:179-185, 1997

194. Rocco MV, Buckalew VM Jr, Moore LC, Shihabi ZK: Capillary electrophoresis for the determination of glomerular filtration rate using nonradioactive iohexol. Am J Kidney Dis 28:173-177, 1996

195. Zelmanovitz T, Gross JL, Oliveira J, de Azevedo MJ: Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy. Diabetes Care 21:1076-1079, 1998

196. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 20:516-519, 1997

197. Ahn CW, Song YD, Kim JH, Lim SK, Choi KH, Kim KR, Lee HC, Huh KB: The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy. Yonsei Med J 40:40-45, 1999

198. Schwab SJ, Dunn FL, Feinglos MN: Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis. Diabetes Care 15:1581-1584, 1992

199. Ng WY, Lui KF, Thai AC: Evaluation of a rapid screening test for microalbuminuria with a spot measurement of urine albumin-creatinine ratio. Ann Acad Med Singapore 29:62-65, 2000

200. Ciavarella A, Silletti A, Forlani G, Morotti L, Borgnino LC, D’Apote M, Vannini P: A screening test for microalbuminuria in type 1 (insulin-dependent) diabetes. Diabetes Res Clin Practice 7:307-312, 1989

201. Webb DJ, Newman DJ, Chaturvedi N, Fuller JH: The use of the Micral-Test strip to identify the presence of microalbuminuria in people with insulin dependent diabetes mellitus (IDDM) participating in the EUCLID study. Diabetes Res Clin Practice 31:93-102, 1996

202. Poulsen PL, Hansen B, Amby T, Terkelsen TE, Mogensen C: Evaluation of a dipstick test for microalbuminuria in three different clinical settings, including the correlation with urinary albumin excretion rate. Diabetes Metab 18:395-400, 1992

203. Gerber LM, Johnston K, Alderman MH: Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension. Am J Hypertens 11:1321-1327, 1998

204. Schwab SJ, Christensen RL, Dougherty K, Klahr S: Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med 147:943-944, 1987

205. Ginsberg JM, Chang BS, Matarese RA, Garella S: Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543-1546, 1983

206. Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain RP, Lewis EJ: The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis 26:904-909, 1995

207. Wilson DM, Anderson RL: Protein-osmolality ratio for the quantitative assessment of proteinuria from a random urinalysis sample. Am J Clin Pathol 100:419-424, 1993

208. Chu NF, Ferng SH, Shieh SD, Fan CD, Shyh TP, Chu PL: Assessment of proteinuria by using the protein/creatinine ratio of single-voided urine. J Formos Med Assoc 89:657-660, 1990

209. Steinhauslin F, Wauters JP: Quantitation of proteinuria in kidney transplant patients: Accuracy of the urinary protein/creatinine ratio. Clin Nephrol 43:110-115, 1995

210. Nathan DM, Rosenbaum C, Protasowicki VD: Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 10:414-418, 1987

211. Cottiero RA, Madaio MP, Levey AS: Glomerular filtration rate and urinary albumin excretion rate in systemic lupus erythematosus. Nephron 140:140-146, 1995

212. Yoshimoto M, Tsukahara H, Saito M, Hayashi S, Haruki S, Fujiswana S, Sudo M: Evaluation of variability of proteinuria indices. Pediatr Nephrol 4:136-139, 1990

213. Iyer RS, Shailaja SN, Bhaskaranand N, Baliga M, Venkatesh A: Quantitation of proteinuria using protein-creatinine ratio in random urine samples. Indian Pediatr 28:463-467, 1991

214. Chahar OP, Bundella B, Chahar CKJ, Purohit M: Quantitation of proteinuria by use of single random spot urine collection. J Indian Med Assoc 91:86-87, 1993

215. Mir S, Kutukcular N, Cura A: Use of single voided urine samples to estimate quantitative proteinuria in children. Turk J Pediatr 34:219-224, 1992

216. Houser MT: Assessment of proteinuria using random urine samples. J Pediatr 104:845-848, 1984

217. Abitbol C, Zilleruelo G, Freundlich M, Strauss J: Quantitation of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic children. J Pediatr 166:243-224, 1990

218. Sochett E, Daneman D: Screening tests to detect microalbuminuria in children with diabetes. J Pediatr 112:744-748, 1988

219. Fivush BA, Jabs K, Sullivan EK, Feld LG, Kohaut E, Fine RN: Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 12:328-377, 1998

220. Kitagawa T: Lessons learned from the Japanese nephritis screening study. Pediatr Nephrol 2:256-263, 1998

221. Committee on Practice and Ambulatory Medicine: Recommendations for preventive pediatric health care. Pediatrics 96:1-4, 1995

222. Kaplan RE, Springate JE, Feld LG: Screening dipstick analysis: A time to change. Pediatrics 100:919-921, 1997

223. American Diabetes Association: Diabetic nephropathy. Diabetes Care 21:S50-S53, 1998

224. The EUCLID Study Group: Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 349:1787-1792, 1997

225. Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving H-H: Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 319:24-25, 1999

226. Ruggenenti P, Pagano E, Tammuzzo L, Benini R, Garattini L: Gruppo Italiano Di Studi Epidemilogici in Nefrologia (GISEN). Kidney Int 59:286-294, 2001

227. Wang PH: When should ACE inhibitors be given to normotensive patients with IDDM? Lancet 349:1782-1783, 1997

228. Grimm RH Jr, Svendsen KH, Kasiske B, Keane WF, Wahi MM: Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 63:S10-S14, 1997 (suppl 63)

229. Couper JJ, Clarke CF, Byrne GC, Jones TW, Donaghue KC, Nairn J, Boyce D, Russell M, Stephens M, Raymond J, Bates DJ, McCaul K: Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus. Diabet Med 14:766-771, 1997

230. Levey AS, Perrone RD, Madaio MP: Laboratory assessment of renal disease: Clearance, urinalysis and renal biopsy, in Brenner BM, Rector FR (eds): The Kidney. Philadelphia, PA, W.B. Saunders, 1991, pp 919-968

231. Norden AG, Scheinman SJ, Deschodt-Lanckman MM, Lapsley M, Nortier JL, Thakker RV, Unwin RJ, Wrong O: Tubular proteinuria defined by a study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney Int 57:240-249, 2000

232. Tomlinson PA, Smellie JM, Prescod N, Dalton RN, Chantler C: Differential excretion of urinary proteins in children with vesicoureteric reflux and reflux nephropathy. Pediatr Nephrol 8:21-25, 1994

233. Weitgasser R, Schnoell F, Gappmayer B, Kartnig I: Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care 22:1882-1886, 1999

234. Kordonouri O, Hartmann R, Mueller C, Danne T, Weber B: Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes. From the Hormone Res 50:S23-S27, 1998 (suppl 1)

235. Reichert LJ, Koene RA, Wetzels JF: Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clin Nephrol 48:79-84, 1997

236. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D’Amico G: Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: Clinical significance and prognostic value of low molecular weight (“tubular”) proteins. Am J Kidney Dis 29:27-35, 1997

237. Woo KT, Lau YK, Lee GS, Wei SS, Lim CH: Pattern of proteinuria in IgA nephritis by SDS-PAGE: Clinical significance. Clin Nephrol 36:6-11, 1991

238. Reichert LJ, Koene RA, Wetzels JF: Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol 6:1666-1669, 1995

239. Hara M, Yanagihara T, Itoh M, Matsuno M, Kihara I: Immunohistochemical and urinary markers of podocyte injury. Pediatr Nephrol 12:43-48, 1998

240. Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, Yamamoto T, Kihara I: Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18:35-41, 1998

241. Hotta O, Taguma Y, Ooyama M, Yusa N, Nagura H: Analysis of CD14+ cells and CD56+ cells in urine using flow cytometry: A useful tool for monitoring disease activity of IgA nephropathy. Clin Nephrol 39:289-294, 1993

242. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H: Urinary podocytes for the assessment of disease activity in lupus nephritis. Am J Med Sci 320:112-116, 2000

243. Nakamura T, Ushiyama C, Suzuki S, Hara M: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15:1379-1383, 2000

244. Wilson PW, Culleton BF: Epidemiology of cardiovascular disease in the United States. Am J Kidney Dis 32:S56-S65, 1998 (suppl 3)

245. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Bethesda, MD, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute, 1997

246. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960-1991. Hypertension 26:6069, 1995 (erratum 27:1192, 1996)

247. Wright JT Jr, Douglas JG, Rahman M: Prevention of cardiovascular disease in hypertensive patients with normal renal function. Am J Kidney Dis 32:S66-S79, 1998 (suppl 3)

248. Mailloux LU, Levey AS. Hypertension in chronic renal disease. Am J Kidney Dis 32:S120-S141, 1998  (suppl 3)

249. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto RDA, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646-661, 2000

250. HCFA-1995: 1995 Annual Report. ESRD core indicator project. Opportunities to improve care for adult in-center hemodialysis patients. Baltimore, MD, Health Care Financing Administration, DHHS, 1996

251. Rocco MV, Flanagan MJ, Beaver S, Frederick P, Gentile DI, McClellan WM, Polder J, Prowant BF, Taylor L, Helgersson SD: Report from the 1995 core indicators for peritoneal dialysis study group. Am J Kidney Dis 30:165-173, 1997

252. National High Blood Pressure Education Program Working Group. 1995 Update of the working group reports on chronic renal failure and renovascular hypertension. Arch Intern Med 156:1938-1947, 1995

253. Parving HH, Andersen AR, Smidt UM: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175-1179, 1983

255. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria and the progression of renal disease: The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754-762, 1995

256. Opelz G, Wujciak T, Ritz E: The Collaborative Transplant Study. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53:217-222, 1998

257. Levin A, Singer J, Thompson CR: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996

258. Lazarus JM, Bourgoignie JJ, Buckalew VM Jr, Milas NC, Paranandi L, Peterson JC, Porush JG, Rauch S, Soucie JM, Stollar C: Achievement and safety of a low blood pressure goal in chronic renal disease. Modification of Diet in Renal Disease Study Group. Hypertension 29:641-650, 1997

259. Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK: Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 12:2597-2602, 1997

260. Foley RN, Parfrey PS, Harnett JD, Dent FM, Murray DC, Barre PC: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996

261. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:112-119, 1998

262. Zagar PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54:561-569, 1998

263. Buckalew VM Jr, Berg RL, Wang SR, Porush JG, Rauch S, Schulman G: Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 28:811-821, 1996

265. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30:S192-S240, 1997 (suppl 3)

266. NKF-KDOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Disease 77:S182-S288, 2001 (suppl 1)

267. McGonigle RJ, Wallin JD, Shadduck RK, Fisher JW: Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 25:437-444, 1984

268. Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM: Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function. Blood 54:877-884, 1979

269. Loge JP, Lange RD, Moore CV: Characterization of the anemia associated with chronic renal insufficiency. Am J Med 24, 1958

270. Ross RP, McCrea JB, Besarab A: Erythropoietin response to blood loss in hemodialysis patients is blunted but preserved. ASAIO J 40:M880-M885, 1994

271. Naets JP, Garcia JF, Tousaaint C, Buset M, Waks D: Radioimmunoassay of erythropoietin in chronic uraemia of anephric patients. Scand J Haematol 37:390-394, 1986

272. World Health Organization: Nutritional Anemia. Report of a WHO Scientific Group. Geneva, Switzerland, WHO, 1968

273. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients With Chronic Renal Failure: European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 14:1-50, 1999 (suppl 5)

274. Erslev AJ, Besarab A: The rate and control of baseline red cell production in hema-tologically stable uremic patients. J Lab Clin Med 126:283-286, 1995

275. Fisher JW: Mechanism of the anemia of chronic renal failure. Nephron 25:106-111, 1980

276. Besarab A, Levin A: Defining a renal anemia management period. Am J Kidney Dis 36:S13-S23, 2000

277. Chandra M, Miller ME, Garcia JF, Mossey RT, McVicar MI: Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. Nephron 39:26-29, 1985

278. Eschbach JW Jr, Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276:653-688, 1967

279. Collins AJ, Ma JZ, Xia A, Ebben J: Trends in anemia treatment with erythropoietin usage and patient outcomes. Am J Kidney Dis 32:S133-S141, 1998 (suppl 4)

280. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11:1277-1285, 1996

281. Levin A, Foley RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 36:S24-S30, 2000 (suppl 3)

282. Kausz AT, Obrador GT, Pereira BJ: Anemia management in patients with chronic renal insufficiency. Am J Kidney Dis 36:S39-S51, 2000 (suppl 3)

283. Locatelli F, Conte F, Marcelli D: The impact of hematocrit levels and Erythropoietin treatment on overall and cardiovascular mortality and morbidity: The experience of Lombardy Registry. NDT 13:1642-1644, 1998

284. Muirhead N, for the Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 300:573-578, 1990

285. The US Recombinant Erythropoietin Predialysis Study Group: Double-blind, placebo controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 18:50-59, 1991

286. Austrian Multicenter Study Group of rHuEPO in predialysis patients: Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Nephron 61:399-403, 1992

287. Winearls CG: Recombinant human erythropoietin: 10 years of clinical experience. Nephrol Dial Transplant 13:3-8, 1998

288. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34:125-134, 1999

289. Taralov Z, Koumtchev E, Lyutakova Z: Erythrocyte ferritin levels in chronic renal failure patients. Folia Medica (Plovdiv) 40:65-70, 1998

290. Clyne N, Jogestrand T, Lins LE, Pehrsson SK: Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity. Nephron 67:322-326, 1994

291. Ishimura E, Nishizawa Y, Okuno S, Matsumoto N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H: Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 11:83-86, 1998

292. de Klerk G, Wilmink JM, Rosengarten PC, Vet RJ, Goudsmit R: Serum erythropoietin (ESF) titers in anemia of chronic renal failure. J Lab Clin Med 100:720-734, 1982

293. Urabe A, Saito T, Fukamachi H, Kubota M, Takaku F: Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states. Int J Cell Cloning 5:202-208, 1987

294. Silverberg DS, Iaina A, Peer G, Kaplan E, Levi BA, Frank N, Steinbruch S, Blum M: Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 27:234-238, 1996

295. Lin JL, Kou MT, Leu ML: Effect of long-term low-dose aluminum-containing agents on hemoglobin synthesis in patients with chronic renal insufficiency. Nephron 74:33-38, 1996

296. Clyne N, Jogestrand T: Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients. Nephron 60:390-396, 1992

297. Portoles J, Torralbo A, Martin P, Rodrigo J, Herrero JA, Barrientos A: Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 29:541-548, 1997

298. Dimitrakov D, Kumchev E, Tllkian E: Study of the effect of recombinant erythropoietin on renal anaemia in predialysis patients with chronic renal failure. Folia Medica (Plovdiv) 36:31-36, 1994

299. Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME: Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol 5:2037-2047, 1995 (erratum 6:1318, 1995)

300. Howard AD, Moore J Jr, Welch PG, Gouge SF: Analysis of the quantitative relationship between anemia and chronic renal failure. Am J Med Sci 297:309-313, 1989

301. Lim VS, Fangman J, Flanigan MJ, DeGowin RL, Abels RT: Effect of recombinant human erythropoietin on renal function in humans. Kidney Int 37:131-136, 1990

302. Besarab A, Caro J, Jarrell B, Burke J, Francos G, Mallon E, Karsch R: Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis. Transplantation 40:624-631, 1985

303. Brod J, Hornych A: Effect of correction of anemia on the glomerular filtration rate in chronic renal failure. Isr J Med Sci 3:53-59, 1967

304. Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW Jr, Shadur CA: Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24:777-784, 1994

305. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O: Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77:176-185, 1997

306. Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M: Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35:250-256, 2000

307. Schwartz AB, Prior JE, Mintz GS, Kim KE, Kahn SB: Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin. Transplant Proc 23:1827-1830, 1991

308. Donnelley S, Shah BE: Erythropoietin deficiency in hyporeninemia. Am J Kidney Dis 33:947-953, 1999

309. Chaplin H, Mollison PL: Red cell life span in nephritis and in hepatic nephrosis. Clin Sci 12:351, 1953

310. Besarab A, Caro J, Jarrell BE, Francos G, Erslev AJ: Dynamics of erythropoiesis following renal transplantation. Kidney Int 32:526-536, 1987

311. Cavill I: Iron status as measured by serum ferritin: The marker and its limitations. Am J Kidney Dis 34:S12-S17, 1999 (suppl 2)

312. Sunder-Plassmann G, Horl W: Erythropoietin and iron. Clin Nephr 47:141-157, 1997

313. Eckard K-U, Möllmann M, Neumann R: Erythropoietin in polycystic kidney. J Clin Invest 84:1160-1166, 1989

314. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 50:343-357, 1996

315. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994

316. Graham KA, Reaich D, Channon SM, Downie S, Goodship TH: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8:632-637, 1997

317. Position of the American Dietetic Association: Cost-effectiveness of medical nutrition therapy. J Am Diet Assoc 95:88-91, 1995

318. Bergstrom J: Nutrition and mortality in hemodialysis. J Am Soc Nephrol 6:1329-1341, 1995

319. Lowrie EG, Huang WH, Lew NL, Liu Y: The relative contribution of measured variables to death risk among hemodialysis patients, in Friedman EA (ed): Death on Hemodialysis. Amsterdam, The Netherlands, Kluwer Academic, 1994, pp 121-141

320. Hakim RM, Lazarus JM: Initiation of dialysis. J Am Soc Nephrol 6:1319-1328, 1995

321. Holland D, Lam M: Predictors of hopitalization and death amongst pre-dialysis patients: A retrospective study. Nephrol Dial Transplant 15:650-658, 2000

322. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM: Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 55:1945-1951, 1999

323. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999

324. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS: Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD study. Kidney Int 57:1688-1703, 2000

325. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386-1391, 1995

326. Mitch WE, Maroni BJ: Nutritional considerations in the treatment of patients with chronic uremia. Miner Electrolyte Metab 24:285-289, 1998

327. Mitch WE, Maroni BJ: Factors causing malnutrition in patients with chronic uremia. Am J Kidney Dis 33:176-179, 1999

328. Ballmer PE, Imoberdorf R: Influence of acidosis on protein metabolism. Nutrition 11:462-468, 1995

329. Tonshoff B, Blum WF, Mehls O: Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int 58:S106-S113, 1997 (suppl 58)

330. Saborio P, Hahn S, Hisano S, Latta K, Scheinmann JI, Chan JC: Chronic renal failure: An overview from a pediatric perspective. Nephron 80:134-148, 1998

331. Boirie Y, Breyer M, Gagnadoux MF, Niaudet P, Bresson JL: Alterations of protein metabolism by metabaolic acidosis in children with chronic renal failure. Kidney Int 58:236-241, 2000

332. Panichi V, Migliori M, De Pietro S: C reactive protein in patients with chronic renal diseases. Ren Fail 23:551-562, 2001

333. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J: Inflammation and acidosis are important independent predictors of hypoalbuminuria in renal insufficiency. J Am Soc Nephrol 12:201A, 2001 (abstr)

334. Bistrian BR: Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. Am J Kidney Dis 32:S113-S117, 1998 (suppl 4)

335. Bistrian BRK: The systemic inflammatory response and its impact on iron nutriture in end-stage renal disease. Am J Kidney Dis 34:S35-S39, 1999 (suppl 2)

336. Bergstrom J, Lindholm B: Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis 32:834-841, 1998

337. Tom K, Young VR, Chapman T, Masud T, Akpele L, Maroni BJ: Long-term adaptive responses to dietary protein restriction in chronic renal failure. Am J Physiol 268:E668-E677, 1995

338. Kopple JD, Berg R, Houser H, Steinman TI, Teschan P: Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int 27:S184-S194, 1989 (suppl 27)

339. Coggins CH, Dwyer JT, Greene T, Petot G, Snetselaar LG, Van Lente F: Serum lipid changes associated with modified protein diets: Results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis 23:514-523, 1994

340. Park JS, Jung HH, Yang WS, Kim HH, Kim SB, Park SK, Hong CD: Protein intake and the nutritional status in patients with pre-dialysis chronic renal failure on unrestricted diet. Korean J Intern Med 12:115-121, 1997

341. Pollock CA, Ibels LS, Zhu FY, Warnant M, Caterson RJ, Waugh DA, Mahony JF: Protein intake in renal disease. J Am Soc Nephrol 8:777-783, 1997

342. Walser M, Mitch WE, Maroni BJ, Kopple JD: Should protein intake be restricted in predialysis patients? Kidney Int 55:771-777, 1999

343. Chauveau P, Barthe N, Rigalleau V, Ozenne S, Castaing F, Delclaux C: Outcome of nutritional status and body composition of uremic patients on a very low protein diet. Am J Kidney Dis 34:500-507, 1999

344. Williams B, Hattersley J, Layward E, Walls J: Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 40:779-786, 1991

345. Aparicio M, Chauveau P, De Precigout V, Bouchet JL, Lasseur C, Combe C: Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 11:708-716, 2000

346. Walser M, Hill SB, Ward L, Magder L: A crossover comparison of progression of chronic renal failure: Ketoacids versus amino acids. Kidney Int 43:933-939, 1993

347. Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Archard JM, Pruna A, Fournier A: Risk factors of renal failure progression two years prior to dialysis. Clin Nephrol 51:355-366, 1999

348. Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD: Energy expenditure in patients with chronic renal failure. Kidney Int 30:741-747, 1986

349. Ando A, Orita Y, Nakata K, Tsubakihara Y, Takamitsu Y, Ueda N, Yanase M, Abe H: Effect of low protein diet and surplus of essential amino acids on the serum concentration and the urinary excretion of methylguanidine and guanidinosuccinic acid in chronic renal failure. Nephron 24:161-169, 1979

350. Stenvinkel P, Heimburger O, Tuck CH, Berglund L: Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 53:1336-1342, 1998

351. Walser M, Hill S: Can renal replacement be deferred by a supplemented very low protein diet? J Am Soc Nephrol 10:110-116, 1999

352. Cupisti A, Guidi A, Giovannetti S: Nutritional state of severe chronic renal failure patients on a low-protein supplemented diet. Contrib Nephrol 81:161-168, 1990

353. Sugimoto T, Kikkawa R, Haneda M, Shigeta Y: Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic patients with nephropathy. J Nutr Sci Vitaminol 37:S87-S92, 1991 (suppl)

354. Guarnieri G, Toigo G, Situlin R, Crapesi L, Del Bianco MA, Zanettovich A, Faccini L, Lucchesi A, Oldrizzi L, Rugiu C: Nutritional assessment in patients with early renal insufficiency on long-term low protein diet. Contrib Nephrol 53:40-50, 1986

355. Di Landro D, Dattilo GA, Romagnoli GF: Comparative outcome of patients on a conventional low protein diet versus a supplemented diet in chronic renal failure. Contrib Nephrol 81:201-207, 1990

356. Vetter K, Kaschube I, Metzner C, Lindenau K, Frohling PT: Evaluation of nutritional status in the GDR trial. Contrib Nephrol 81:208-213, 1990

357. Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, Giovannetti S: Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 29:280-287, 1988

358. Jenkins D, Burton PR, Bennett SE, Baker F, Walls J: The metabolic consequences of the correction of acidosis in uraemia. Nephrol Dial Transplant 4:92-95, 1989

359. Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimaki T: Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years. Nephron 80:17-24, 1998

360. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR: Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324:78-84, 1991

361. D’Amico G, Gentile MG: Dietary control may influence several risk factors in patients with chronic renal failure. Contrib Nephrol 81:29-34, 1990

362. Parillo M, Riccardi G, Pacioni D, Iovine C, Contaldo F, Isernia C, De Marco F, Perrotti N, Rivellese A: Metabolic consequences of feeding a high-carbohydrate, high-fiber diet to diabetic patients with chronic kidney failure. Am J Clin Nutr 48:255-259, 1988

363. Goodship TH, Mitch WE, Hoerr RA, Wagner DA, Steinman TI, Young VR: Adaptation to low-protein diets in renal failure: Leucine turnover and nitrogen balance. J Am Soc Nephrol 1:66-75, 1990

364. Woodrow G, Oldroyd B, Smith MA, Turney JH: Measurement of body composition in chronic renal failure: Comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. Eur J Clin Nutr 50:295-301, 1996

365. Guarnieri GF, Toigo G, Situlin R, Carraro M, Tamaro G, Lucchesli A, Oldrizzi L, Rugiu C, Maschio G: Nutritional state in patients on long-term low-protein diet or with nephrotic syndrome. Kidney Int 27:S195-S200, 1989 (suppl 27)

366. Maroni BJ, Staffeld C, Young VR, Manatunga A, Tom K: Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J Clin Invest 99:2479-2487, 1997

367. Mitch WE, Walser M, Steinman TI, Hill S, Zeger S, Tungsanga K: The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 311:623-629, 1984

368. Milas NC, Nowack MP, Akpele L, Castaldo L, Coyne T, Doroshenko L, Kigawa L, Korzec-Ramirez D, Scherch LK, Snetselaar L: Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. J Am Diet Assoc 95:1295-1300, 1995

369. Gillis BP, Caggiula AW, Chiavacci AT: Nutrition intervention program of the Modification of Diet in Renal Disease Study: A self-management approach. J Am Diet Assoc 95:1288-1294, 1995

370. Coyne T, Olson M, Bradham K, Garcon M, Gregory P, Scherch L: Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. J Am Diet Assoc 95:1301-1306, 1995

371. Dolecek T, Olsen MB, Caggiula AW, Dwyer JT, Milas C, Gillis BP, Hartmann JA, DiChiro JT: Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. J Am Diet Assoc 95:1307-1312, 1995

372. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV: The spectrum of bone disease in end-stage renal failure—An evolving disorder. Kidney Int 43:436-442, 1993

373. Bushinsky DA: The contribution of acidosis to renal osteodystrophy. Kidney Int 47:1816-1832, 1995

374. Coen G, Manni M, Addari O, Ballanti P, Pasquali M, Chicca S, Mazzaferro S, Mapoletano I, Napoletano I, Sardella D, Bonucci E: Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: Effect of calcitriol treatment. Miner Electrolyte Metab 21:375-382, 1995

375. Hsu CH: Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29:641-649, 1997

376. Sherrard DJ: Control of renal bone disease. Semin Dial 7:284-287, 1994

377. Slatopolsky E, Bricker NS: The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 4:141-145, 1973

378. Kates DM, Sherrard DJ, Andress DL: Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 30:809-813, 1997

379. Llach F, Massry SG: On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 61:601-606, 1985

380. Budisavljevic M, Cheek D, Ploth D: Calciphylaxis in chronic renal failure. J Am Soc Nephrol 7:978-982, 1996

381. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401, 1996

382. Andress DL, Maloney NA, Endres DB, Sherrard DJ: Aluminum-associated bone disease in chronic renal failure: High prevalence in a long-term dialysis population. J Bone Miner Res 1:391-398, 1986

383. Ferreira M: Diagnosis of renal osteodystrophy: When and how to use biochemical markers and non-invasive methods: When bone biopsy is needed. Nephrol Dial Transplant 15:S8-S14, 2000 (suppl)

384. Malluche HH, Langub MC, Monier-Faugere MC: The role of bone biopsy in clinical practice and research. Kidney Int 73:S20-S25, 1999 (suppl 73)

385. Slatopolsky E, Brown A, Dusso A: Pathogenesis of secondary hyperparathyroidism. Kidney Int 73:S14-S19, 1999 (suppl 73)

386. Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y: Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836-844, 1995

387. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622-631, 1995

388. Eastwood JB, Bordier PJ, de Wardener HE: Some biochemical, histological, radiological and clinical features of renal osteodystrophy. Kidney Int 4:128-140, 1973

389. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, de Bonis E, Darias E, Gonzalez-Posada JM: Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47:1434-1442, 1995

390. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ: Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534-2540, 1996

391. Wilson L, Felsenfeld A, Drezner MK, Llach F: Altered divalent ion metabolism in early renal failure: Role of 1,25(OH)2D. Kidney Int 27:565-573, 1985

392. Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT: Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358-363, 1995

393. Delmez JA, Slatopolsky E. Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19:303-317, 1992

394. Llach F: Hyperphosphatemia in end-stage renal disease patients: Pathophysiological consequences. Kidney Int 73:S31-S37, 1999 (suppl 73)

395. Khosla S, Melton LJ III, Wermers RA, Crowson CS, O’Fallon W, Riggs B: Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700-1707, 1999

396. Bruce DG, St John A, Nicklason F, Goldswain PR: Secondary hyperparathyroidism in patients from Western Australia with hip fracture: Relationship to type of hip fracture, renal function, and vitamin D deficiency. J Am Geriatr Soc 47:354-359, 1999

397. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L: Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321:598-602, 2000

398. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T: Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287-293, 1999

400. Block GA, Port FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35:1226-1237, 2000

401. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607-617, 1998

402. Lau K: Phosphate excess and progressive renal failure: The precipitation-calcification hypothesis. Kidney Int 36:918-937, 1989

403. Avram MM, Fein PA, Bonomini L, Mittman N, Loutoby R, Avram DK, Chattopadhyay J: Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study. Perit Dial Int 16:S190-S194, 1996 (suppl 1)

404. Carlstedt F, Lind L, Wide L, Lindahl B, Hanni A, Rastad J, Ljunghall S: Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 27:977-981, 1997

405. Martinez I, Saracho R, Montenegro J, Llach F: The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29:496-502, 1997

406. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB: Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrin Metab 67:876-881, 1988

407. St John A, Thomas MB, Davies CP, Mullan B, Dick I, Hutchison B, van der SA, Prince RL: Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron 61:422-427, 1992

408. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E: Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 6:162-169, 1991

409. von Lilienfeld-Toal H, Gerlach I, Klehr HU, Issa S, Keck E: Immunoreactive parathyroid hormone in early and advanced renal failure. Nephron 31:116-122, 1982

410. Cheung AK, Manolagas SC, Catherwood BD, Mosely CA Jr, Mitas JA, Blantz RC, Deftos LJ: Determinants of serum 1,25(OH)2D levels in renal disease. Kidney Int 24:104-109, 1983

411. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS: Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 57:329-335, 1995

412. Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K: Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084-1093, 1999

413. Yumita S, Suzuki M, Akiba T, Akizawa T, Seino Y, Kurokawa K: Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure. Tohoku J Exp Med 180:45-56, 1996

414. Christensen MS, Nielsen HE: Parathyroid function after renal transplantation: Interrelationships between renal function, serum calcium and serum parathyroid hormone in normocalcemic long-term survivors. Clin Nephrol 8:472-476, 1977

415. Malluche HH, Ritz E, Lange HP, Kutschera L, Hodgson M, Seiffert U, Schoeppe W: Bone histology in incipient and advanced renal failure. Kidney Int 9:355-362, 1976

416. McGonigle RJ, Wallin JD, Husserl F, Deftos LJ, Rice JC, O’Neill WJ Jr, Fisher JW: Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure. J Lab Clin Med 104:1016-1026, 1984

417. Saha H: Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 41:290-296, 1994

418. Messa P, Mioni G, Turrin D, Guerra UP: The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. Nephrol Dial Transplant 10:2259-2265, 1995

419. Tessitore N, Venturi A, Adami S, Roncari C, Rugiu C, Corgnati A, Bonucci E, Maschio G: Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. Miner Electrolyte Metab 13:38-44, 1987

420. Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonucci E, Taggi E: Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. Miner Electrolyte Metab 15:295-302, 1989

421. Tougaard L, Sorensen E, Christensen MS, Brochner-Mortensen J, Rodbro P, Sorensen AW: Bone composition and parathyroid function in chronic renal failure. Acta Med Scand 202:33-38, 1977

422. Madsen S, Olgaard K, Ladefoged J: Renal handling of phosphate in relation to serum parathyroid hormone levels. Acta Med Scand 200:7-10, 1976

423. Bedani PL, Tamarozzi R, Pinna L, Gilli P, Perini L, Farinelli A: Early skeletal changes of the hand phalanges in patients with chronic renal failure. Int J Artif Organs 8:325-330, 1985

424. Arata RO, Campos C, Mautalen CA: Effect of parathyroid hormone on bone resorption in uremic patients. Medicina (Mex) 36:113-120, 1976

425. Arnaud CD: Hyperparathyroidism and renal failure. Kidney Int 4:89-95, 1973

426. Reiss E, Canterbury JM, Egdahl RH: Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians 81:104-115, 1968

427. Massry SG, Coburn JW, Lee DB, Jowsey J, Kleeman CR: Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects. Ann Intern Med 78:357-364, 1973

428. Slatopolsky E, Robson AM, Elkan I, Bricker NS: Control of phosphate excretion in uremic man. J Clin Invest 47:1865-1874, 1968

429. Coburn JW, Koppel MH, Brickman AS, Massry SG: Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 3:264-272, 1973

430. Coburn JW, Popovtzer MM, Massry SG, Kleeman CR: The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med 124:302-311, 1969

431. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H: Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55:1019-1027, 1999

432. Nielsen SP, Sorensen OH, Lund B, Barenholdt O, Munck O, Pedersen K: Calcium metabolism in patients with chronic non-dialytic renal disease. Calcif Tissue Res 21:202-209, 1976 (suppl)

433. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, Gokal R: Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 44:1071-1077, 1993

434. Suzuki M, Hirasawa Y: Renal osteodystrophy in early chronic renal failure. Contrib Nephrol 22:28-38, 1980

435. Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F: Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study. Nephrol Dial Transplant 11:813-819, 1996

436. Madsen S, Olgaard K, Ladefoged J: Degree and course of skeletal demineralization in patients with chronic renal insufficiency. Scand J Urol Nephrol 12:243-249, 1978

437. Local Medicare Review Policy Website. Website: www.lmrp.net, 6/26/01

438. Burn DJ, Bates D: Neurology and the kidney. J Neurol Neurosurg Psychiatry 65:810-821, 1998

439. Fraser C, Arieff A: Nervous system manifestations of renal failure, in Schrier RW, Gottschalk CW (ed): Diseases of the Kidney. Boston, MA, Little, Brown, 1993, pp 2804-2809

440. Bazzi C, Pagani C, Sorgato G, Albonico G, Fellin G, D’Amico G: Uremic polyneuropathy: A clinical and electrophysiological study in 135 short- and long-term hemodialyzed patients. Clin Nephrol 35:176-181, 1991

441. Wetter TC, Stiasny K, Kohnen R, Oertel WH, Trenkwalder C: Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome. Mov Disord 13:820-824, 1998

442. Weinrauch LA, D’Elia JA, Gleason RE, Keough J, Mann D, Kennedy FP: Autonomic function in type I diabetes mellitus complicated by nephropathy. A cross-sectional analysis in the presymptomatic phase. Am J Hypertens 8:782-789, 1995

443. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG: Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 20:246-253, 1981

444. Sterner NG, Nilsson H, Rosen U, Lilja B, Sundkvist G: Relationships among glomerular filtration rate, albuminuria, and autonomic nerve function in insulin-dependent and non-insulin-dependent diabetes mellitus. J Diabetes Complications 11:188-193, 1997

445. Di Paolo B, Cappelli P, Spisni C, Albertazzi A, Rossini PM, Marchionno L, Gambi D: New electrophysiological assessments for the early diagnosis of encephalopathy and peripheral neuropathy in chronic uraemia. Int J Tissue React 4:301-307, 1982

446. Savazzi GM, Migone L, Cambi V: The influence of glomerular filtration rate on uremic polyneuropathy. Clin Nephrol 13:64-72, 1980

447. Goel MK, Gulati PD, Janki S, Ram SR, Raina V, Rizvi SN: Observations on peripheral neuropathy in chronic uraemics. J Assoc Physicians India 26:341-346, 1978

448. Nielsen VK: The peripheral nerve function in chronic renal failure. VI. The relationship betweeen sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. Acta Med Scand 194:455-462, 1973

449. Knoll O, Dierker E: Detection of uremic neuropathy by reflex response latency. J Neurol Sci 47:305-312, 1980

450. Teschan PE, Ginn HE, Bourne JR, Ward JW, Hamel B, Nunnally JC, Musso M, Vaughn WK: Quantitative indices of clinical uremia. Kidney Int 15:676-697, 1979

451. Savazzi GM: Nerve conduction times in uremia. Int J Artif Organs 4:211-212, 1981

452. Kutner NG: Assessing end-stage renal disease patients’ functioning and well-being: measurement approaches and implications for clinical practice. Am J Kidney Dis 24:321-333, 1994

453. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M: The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 262:925-930, 1989

454. Rettig RA, Sadler JH, Meyer KB, Wasson JH, Parkerson GR Jr, Kantz B, Hays RD, Patrick DL: Assessing health and quality of life outcomes in dialysis: A report on an Institute of Medicine workshop. Am J Kidney Dis 30:140-155, 1997

455. DeOreo PB: Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 30:204-212, 1997

456. Johansen KL: Physical functioning and exercise capacity in patients on dialysis. Adv Renal Repl Ther 6:141-148, 1999

457. Kutner NG, Cardenas DD, Bower JD: Rehabilitation, aging and chronic renal disease. Am J Phys Med Rehabil 71:97-101, 1992

458. Ifudu O, Mayers J, Matthew J, Tan CC, Cambridge A, Friedman EA: Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA 271:29-33, 1994

459. Harris LE, Luft FC, Rudy DW, Tierney WM: Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis 21:161-166, 1993

460. Bardage C, Isacson DG: Hypertension and health-related quality of life. An epidemiological study in Sweden. J Clin Epidemiol 54:172-181, 2001

461. Hall SE, Criddle RA, Comito TL, Prince RL: A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int 9:508-515, 1999

462. Schneider SM, Pouget I, Staccini P, Rampal P, Hebuterne X: Quality of life in long-term home enteral nutrition patients. Clin Nutr 19:23-28, 2000

463. Ahroni JH, Boyko EJ: Responsiveness of the SF-36 among veterans with diabetes mellitus. J Diabetes Complications 14:31-39, 2000

464. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE: The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 7:763-773, 1996

465. Revicki DA, Brown RE, Feeny DH, Henry DA, Teehan BP, Rudnick MR, Benz RL: Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 25:548-554, 1995

466. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111:992-1000, 1989

467. Evans RW, Rader B, Manninen DL: The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 263:825-330, 1990

468. Moreno F, Aracil F, Perez R, Valderrabano F: Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia. Am J Kidney Dis 27:548-556, 1996

469. Rocco MV, Gassman JJ, Wang SR, Kaplan RM: Cross-sectional study of quality of life and symptoms in chronic renal disease patients: The Modification of Diet in Renal Disease Study. Am J Kidney Dis 29:888-896, 1997

470. Korevaar JC, Jansen MA, Merkus MP, Dekker FW, Boeschoten EW, Krediet RT: Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. The NECOSAD Study Group. Perit Dial Int 20:69-75, 2000

471. Shidler NR, Peterson RA, Kimmel PL: Quality of life and psychosocial relationships in patients with chronic renal insufficiency. Am J Kidney Dis 32:557-566, 1998

472. Klang B, Bjorvell H, Clyne N: Quality of life in predialytic uremic patients. Qual Life Res 5:109-116, 1996

473. Fujisawa M, Ichikawa Y, Yoshiya K, Isotani S, Higuchi A, Nagano S, Arakawa S, Hamami G, Matsumoto O, Kamidono S: Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology 56:201-206, 2000

474. Griep MI, Van der Niepen P, Sennesael JJ, Mets TF, Massart DL, Verbeelen DL: Odour perception in chronic renal disease. Nephrol Dial Transplant 12:2093-2098, 1997

475. Sacks CR, Peterson RA, Kimmel PL: Perception of illness and depression in chronic renal disease. Am J Kidney Dis 15:31-39, 1990

476. Manninen DL, Evans RW, Dugan MK: Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. Clin Transplant 5:193-203, 1991

477. Churchill DN, Torrance GW, Taylor DW, Barnes CC, Ludwin D, Shimizu A, Smith EKM: Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 10:14-20, 1987

478. Black SA, Goodwin JS, Markides KS: The association between chronic diseases and depressive symptomatology in older Mexican Americans. J Gerontol Series A Biol Sci Med Sci 53:M188-M194, 1998

479. Cagney KA, Wu AW, Fink NE, Jenckes MW, Meyer KB, Bass EB, Powe NR: Formal literature review of quality of llife instruments used in end stage renal disease. Am J Kidney Dis 36:327-336, 2000

480. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51:1908-1919, 1997

481. Pei Y, Cattran D, Greenwood C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42:960-966, 1992

482. Chitalia VC, Wells JE, Robson RA, Searle M, Lynn KL: Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney Int 56:2236-2242, 1999

483. Levey AS: Nephrology Forum: Measurement of renal function in chronic renal disease. Kidney Int 38:167-184, 1990

484. Walser M: Progression of chronic renal failure in man. Kidney Int 37:1195-1210, 1990

485. Mitch WE, Walser M, Buffington GA, Lemann J: A simple method of estimating progression of chronic renal failure. Lancet 2:1326-1328, 1976

486. Rekola S, Bergstrand A, Bucht H: Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int 40:1050-1054, 1991

487. Austin SM, Lieberman JS, Newton LD, Mejia M, Peters WA, Myers BD: Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease. J Am Soc Nephrol 3:1358-1370, 1993

488. Dillon JJ: The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis 22:798-802, 1993

489. Gall MA, Nielsen FS, Smidt UM, Parving HH: The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 36:1071-1078, 1993

490. Hannedouche T, Albouze G, Chauveau P, Lacour B, Jungers P: Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis 21:131-137, 1993

491. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 9:1097-1102, 1994

492. Levey AS, Adler S, Caggiula A, England BK, Greene T, Hunsicker L, Kusek JW, Rogers NL, Teschan PE: Effects of dietary protein restriction on the progression of moderate renal disease in the MDRD Study. J Am Soc Nephrol 7:2626-2625, 1996

494. Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G: Glomerular hyperfiltration in the prediction of nephropathy in IDDM: A 10-year follow-up study. Diabetes 45:1729-1733, 1996

495. Ellis D, Lloyd C, Becker DJ, Forrest KY, Orchard TJ: The changing course of diabetic nephropathy: Low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. Am J Kidney Dis 27:809-818, 1996

496. Baboolal K, Evans C, Moore RH: Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 31:971-977, 1998

497. Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Bled F, Le Jeune JJ, Fressinaud P, Marre M: Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. Clin Nephrol 48:92-97, 1997

498. Nielsen S, Schmitz A, Rehling M, Mogensen CE: The clinical course of renal function in NIDDM patients with normo- and microalbuminuria. J Intern Med 241:133-141, 1997

499. Massy ZA, Khoa TN, Lacour B, Descamps-Latscha B, Man NK, Jungers P: Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 14:2392-2397, 1999

500. Ruggenenti P, Perna A, Zoccali C, Gherardi G, Benini R, Testa A, Remuzzi G: Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: Differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (GISEN). J Am Soc Nephrol 11:88-96, 2000

501. Hannedouche T, Chauveau P, Kalou F, Albouze G, Lacour B, Jungers P: Factors affecting progression in advanced chronic renal failure. Clin Nephrol 39:312-320, 1993

502. Shah BV, Levey AS: Spontaneous changes in the rate of decline in reciprocal serum creatinine: Errors in predicting the progression of renal disease from extrapolation of the slope. J Am Soc Nephrol 2:1186-1191, 1992

503. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, Klahr S: Dietary protein restriction and the progression of chronic renal disease: What have all the results of the MDRD Study shown? J Am Soc Nephrol 10:2426-2439, 1999

504. Mitch WE: Nephrology Forum: Dietary protein restriction in patients with chronic renal failure. Kidney Int 40:326-341, 1991

505. Biesenbach G, Zazgornik J: High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy. Ren Fail 16:263-272, 1994

506. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S: Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 50:1641-1650, 1996

507. Bakris GL, Mangrum A, Copley JB, Vicknair N, Sadler R: Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. Hypertension 1997:744-750, 1997

508. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH: Progression of diabetic nephropathy. Kidney Int 59:702-709, 2001

509. US Renal Data System. USRDS 1999 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999

510. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13:I80-I93, 1989

511. Walker WG: Hypertension-related renal injury: A major contributor to end-stage renal disease. Am J Kidney Dis 22:164-173, 1993 (erratum 22:626, 1993)

512. Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, Szklo M, Brancati FL: A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: The Atherosclerosis Risk in Communities study. Arch Intern Med 159:1777-1783, 1999

513. Breyer JA, Bain RP, Evans JK, Nahman NS Jr, Lewis EJ, Cooper M, McGill J, Berl T: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int 50:1651-1658, 1996

514. Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC: The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 22:743-751, 1999

515. Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, Wedel H, Weiss L, Alaupovic P: Plasma levels of lipoprotein (a) do not reflect progression of human chronic renal failure. Nephrol Dial Transplant 11:2237-2243, 1996

516. Nakano S, Ogihara M, Tamura C, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K: Reversed circadian blood pressure rhythm independently predicts endstage renal failure in non-insulin-dependent diabetes mellitus subjects. J Diab Comp 13:224-231, 1999

517. Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P: Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12:1908-1915, 1997

518. Ruggenenti P, Gambara V, Perna A, Bertani T, Remuzzi G: The nephrology of non-insulin-dependent diabetes: Predictors of outcome relative to diverse patterns of renal injury. J Am Soc Nephrol 9:2336-2343, 1998

519. Tu WH, Petitti DB, Biava CG, Tulunay O, Hopper J Jr: Membranous nephropathy: Predictors of terminal renal failure. Nephron 36:118-124, 1984

520. Toth T, Takebayashi S: Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis. Int Urol Nephrol 26:93-106, 1994

521. Jacobsen S, Starklint H, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem Hansen G, Skaarup B, Hansen TM: Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol 28:288-299, 1999

522. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158:998-1004, 1998

523. Rosman JB, Langer K, Brandl M, Piers-Becht TP, van der Hem GK, ter Wee PM, Donker AJ: Protein-restricted diets in chronic renal failure: A four year follow-up shows limited indications. Kidney Int 27:S96-S102, 1989 (suppl 27)

524. Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A: Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet 337:1299-1304, 1991

525. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori V: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40:405-411, 1997

526. Standards of Medical Care for Patients with Diabetes Mellitus, Position Statement. Clinical Practice Recommendations 2001. Diabetes Care 24:S33-S43, 2001 (suppl 1)

527. Diabetic Nephropathy, Position Statement. Clinical Practice Recommendations 2001, www.diabetes.org/clinicalrecommendations/Supplement101/S69.htm, 6/26/01

528. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993

529. Microalbuminuria Collaborative Study Group, United Kingdom: Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. BMJ 311:973-977, 1995

530. United Kingdom Prospective Diabetes Study Group: UK Prospective Diabetes Study 33: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998

531. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995

532. Gaede PV, Vedel P, Parving HH, Pedersen O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 353:617-622, 1999

533. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents: Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics 98:649-658, 1996

534. Brown MJ, Palmer CR, Casaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM: Morbidity and mortality in patients randomised to double-blind treatment wit a long-acting calcium-channel blocker or diuretic the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 356:366-372, 2000

535. Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersen B, Wester P-O, Hedner T, de Faire U: STOP-Hypertension-2 Study Group. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular Mortality and Mrobidity in the Swedish Trial in Old Patients with Hypertension-2 Study. Lancet 354:1751-1756, 1999

536. Parving HH: Diabetic hypertensive patients. Is this a group in need of particular care and attention? Diabetes Care 22:B76-B79, 1999 (suppl 2)

537. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 317:703-713, 1998

538. Hansson L, Zanchett A, Carruthers SG, Bahlof B, Elmsfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood pressure lowering a low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. The HOT Study Group. Lancet 351:1755-1762, 1998

539. Ruggenenti P, Remuzzi G: Angiotensin-converting enzyme inhibitor therapy for nondiabetic progressive renal diseas. Curr Opin Nephrol Hypertens 6:489-495, 1997

540. Weir MR, Dworkin L: Antihypertensive drugs, dietary salt, and renal protection: How low should you go with which therapy? Am J Kidney Dis 32:1-22, 1998

541. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001

542. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H, Remuzzi G, Snappinn SM, Zhang Z, Shahinfav S: The RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001

543. Estacio ROM, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338:645-652, 1998

544. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BE, Wester PO, Bjorck J: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 353:611-616, 1999

545. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:143-153, 2000

546. Jafar TH, Schmid CH, Landa M, Giatras I, Toto RDA, Remuzzi G, Maschio G, Brenner BM, et al, for the AIPRD Study Group: Angiotensin-converting enzyme inhibitors and the progression of non-diabetic renal disease: A meta-analysis of patient level data. Ann Intern Med 135:73-87, 2001

547. Agodoa LY, Appel L, Bakris GL, Beck GJ, Bourgoignie JJM, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O’Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S: African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 285:2719-2728, 2001

548. Teschan PE, Beck GJ, Dwyer JT, Greene T, Klahr S, Levey AS, Mitch WE, Snetselaar LG, et al: Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: A reanalysis of the MDRD feasibility study. Clin Nephrol 50:273-283, 1998

549. Pedrini MT, Levey AS, Lau JY, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis. Ann Intern Med 124:627-632, 1996

550. Kasiske BL, Lakatua JD, Ma JZ, Louis TA: A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31:954-961, 1998

551. Krolewski AS, Warram JHG, Christlieb AR: Hypercholesterolemia—A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 45:S125-S131, 1994 (suppl 45)

552. Mänttäri M, Tiula E, Alikoski T, Manninen V: Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension. Hypertension 26:670-675, 1995

553. Gall MA, Hougaard P, Borch-Johnsen K, Parving H-H: Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study. BMJ 314:783-788, 1997

554. Muntner PM, Coresh J, Smith JC, Eckfeldt J, Klag MJ: Plasma lipids and risk of developing renal dysfunction: The atherosclerosis risk in communities study. Kidney Int 58:293-301, 2000

555. Scanferla F, Toffoletto PP, Roncali D, Bazzato G: Associated effect of hepatic hydroxymethylglutaryl coenzyme A reductase + angiotensin converting enzyme inhibitors on the progression of renal failure in hypertensive subjects. Am J Hypertens 4:868, 1991

556. Hommel E, Andersen P, Gall M-A, Nielsen FSA, Jensen BSS, Rossing P: Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia 35:447-451, 1992

557. Nielsen S, Schmitz O, Moller N, Porksen N, Klausen IC, Alberti KGMM: Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36:1079-1086, 1993

558. Thomas ME, Harris KP, Ramaswamy C, Hattersley JM, Wheeler DC, Varghese Z, Williams JD, Walls J, Moorhead JF: Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 44:1124-1129, 1993

559. Aranda Arcas JL, Sanchez RAM, Guijarro C, Araque A, Pulido F, Praga M, Damiano A: [Effect of pravastatin on hypercholesterolemia associated with proteinuria]. Ann Med Interna 11:523-527, 1994

560. Lam KSL, Cheng IKP, Janus ED, Pang RWC: Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38:604-609, 1995

561. Rayner BL, Byrne MJ, van Zyl Smit R: A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone. Clin Nephrol 46:219-224, 1996

562. Smulders YMR, Van Eeden AE, Stehouwer CDA, Weijers RNM, Slaats EH, Silberbusch J: Can reduction in hypertriglyceridemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus? Eur J Clin Invest 27:997-1002, 1997

563. Tonolo G, Ciccarese M, Brizzi P, Puddu L, Secchi G, Calvia P: Reduction of albumin excretion rate in normotensive microalbumiuric type 2 diabetic pateints during long-term simvastatin treatment. Diabetes Care 20:1891-1895, 1997

564. Olbricht CJ, Wanner C, Thiery J, Basten A: Simvastatin in Nephrotic Syndrome Study Group. Simvastatin in nephrotic syndrome. Kidney Int 71:S113-S166, 1999

565. Nishimura M, Sasaki T, Oishi A, Oishi M, Kono S, Toya Y: Angiotensin converting enzyme inhibitor and probucol suppress time-dependent increase in urinary type IV collagen excretion of NIDDM with early nephropathy. J Am Soc Nephrol 10:131A, 1999 (abstr)

566. Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G: Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. Clin Pharmacol Ther 64:427-431, 2000

567. Fried LF, Orchard TJ, Kasiske BL: The effect of lipid reduction on renal disease progression: A meta-analysis. Kidney Int 59:260-269, 2001

568. Albertazzi A, Di Liberato L, Daniele F, Battistel V, Colombi L: Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: Results of a multicenter study. Int J Artif Organs 21:12-18, 1998

569. Jungers P, Choukroun G, Oualim Z, Robino C, Nguyen AT, Man NK: Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 16:307-312, 2001

570. Stoves J, Inglis H, Newstead CG: A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Nephrol Dial Transplant 18:967-974, 2001

571. Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A: The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Clin Nephrol 55:212-219, 2001

572. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 334:1448-1460, 1996

573. Adcox MJ, Collins B, Zager RA: The differential diagnosis of acute renal failure. Contemp Issues Nephrol 25:73-77, 1992

574. Perna A, Remuzzi G: Abnormal permeability to proteins and glomerular lesions: A meta-analysis of experimental and human studies. Am J Kidney Dis 27:34-41, 1996

575. Decker T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T: Microalbuminuria: Implications for micro and macrovascular disease. Diabetes Care 15:1181-1191, 1992

576. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH: Kidney Disease in Diabetes: Diabetes in America (ed 2). Washington, DC, National Diabetes Data Group, US Department of Health and Human Services, 1995, pp 349-400

577. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 37:1000-1004, 1988

578. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984

579. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1:17-19, 1984

580. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T: Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 144-148, 1987

581. Gall MA: Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences. Dan Med Bull 44:465-485, 1997

582. Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T: Microalbuminuria: Implications for micro and macrovascular disease. Diabetes Care 15:1181-1191, 1992

583. Mogensen CE, Damsgaard EM, Froland A, Nielsen S, de Fine Olivarius N, Schmitz A: Microalbuminuria in non-insulin-dependent diabetes. Clin Nephrol 38:528-538, 1992

584. Gilbert RE, Cooper ME, McNally PC, O’Brien RC, Toft J, Jerums G: Microalbuminuria: Prognostic and therapeutic implications in diabetes mellitus. Diabetes Med 11:636-645, 1994

585. Alzaid AA: Microalbuminuria in patients with NIDDM: An overview. Diabetes Care 19:79-89, 1996

586. Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413-1418, 1997

587. Viberti GC, Yip-Messent J, Morocutti A: Diabetic nephropathy. Future avenue. Diabetes Care 15:1216-1225, 1992

588. Orchard TJ, Stevens LK, Forrest KY-Z, Fuller JH: Cardiovascular disease in insulin-dependent diabetes mellitus: Similar rates but different risk factors in the US compared with Europe. Int J Epidemiol 27:976-983, 1998

589. Epstein M, Parving HH, Ruilope LM: Surrogate endpoints and renal protection: Focus on microalbuminuria. Blood Press Suppl 2:52-57, 1997

590. Stehouwer CD, Donker AJ: Clinical usefulness of measurement of urinary albumin excretion in diabetes mellitus. Neth J Med 42:175-186, 1993

591. Panayiotou BN: Microalbuminuria: Pathogenesis, prognosis and management. J Int Med Res 22:181-201, 1994

592. de Cotret PR: Relationships among diabetes, microalbuminuria, and ACE inhibition. J Cardiovasc Pharmacol 32:S9-S17, 1998 (suppl 2)

593. McKenna K, Thompson C: Microalbuminuria: A marker to increased renal and cardiovascular risk in diabetes mellitus. Scott Med J 42:99-104, 1997

594. Mogensen CE: Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas. Diabetologia 42:263-285, 1999

595. Poirier SJ: Preserving the diabetic kidney. J Fam Pract 46:21-27, 1998

596. Feldt-Rasmussen B, Borch-Johnsen K, Deckert T, Jensen G, Jensen JS: Microalbuminuria: An important diagnostic tool. J Diabetes Complications 8:137-145, 1994

597. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee EJ: Proteinuria and mortality in diabetes: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Med 12:149-155, 1994

598. Lee K-U, Park JY, Kim SW, Lee MII, Kim GS, Park S-K, Park J-S: Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 18:793-799, 1995

599. John L, Rao PSSS, Kanagasabapathy AS. Prevalence of diabetic nephropathy in non-insulin dependent diabetics. Indian J Med Res 94:24-29, 1991

600. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK: Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am Epidemiol 142:254-268, 1995

601. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, Garrison RJ, Liebow IM, Howard BV, Bennett PH: Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81:987-995, 1990

602. Klein R, Klein BEK: Vision disorders in diabetes: Diabetes in America. Washington, DC, US Department of Health and Human Services, 1995, pp 293-338

603. Chavers BM, Mauer SM, Ramsay RC, Steffes MW: Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 43:441-446, 1994

604. Parving H-H, Gall M-A, Skøtt P, Jørgensen HE, Løkkegaard H, Jørgensen F, Nielsen B, Larsen S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758-762, 1992

605. Vigstrup J, Mogensen CE: Proliferative diabetic retinopathy: At risk patients identified by early detection of microalbuminuria. Acta Ophthalmol (Copenh) 63:530-534, 1985

606. Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW: Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis 31:947-953, 1998

607. National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes. Bethesda, MD, National Institutes of Health, National Heart, Lung, and Blood Institute, 1995

608. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001

609. Management of dyslipidemia in adults with diabetes. Diabetes Care 24:S58-S61, 2001 (suppl 1)

610. Aspirin therapy in diabetes. Diabetes Care 24:S62-S63, 2001 (suppl 1)

611. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21:1551-1559, 1998

612. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch WE, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146, 1999

613. Diabetic retinopathy. Diabetes Care 24:S73-S76, 2001 (suppl 1)

614. Diabetic retinopathy. Preferred Practice Pattern. San Francisco, CA, American Academy of Ophthalmology (AAO), 1998

615. American Optometric Association Consensus Panel on Diabetes: Care of the Patient With Diabetes Mellitus (ed 2). St Louis, MO, American Optometric Association, 1998

616. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care 15:1080-1107, 1992

617. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985

618. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC: Effect of proteinuria on mortality in NIDDM. Diabetes 37:1499-1504, 1988

619. Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127-1133, 1999

620. Foley RN, Parfrey PS, Harnett JD: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995

621. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10:1606-1615, 1999

622. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999

623. Levy D, Garrison RJ, Savage DD: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566, 1990

624. Morbidity and Mortality: 1998 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD, US Dept of Health and Human Services, 1998

625. Wannamethee SG, Shaper AG, Perry IJ: Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. Stroke 28:557-563, 1997

626. Beto JA, Bansal VK: Interventions for other risk factors: Tobacco use, physical inactivity, menopause, and homocysteine. Am J Kidney Dis 32:S112-S119, 1998 (suppl 3)

627. Kasiske BL: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32:S142-S156, 1998 (suppl 3)

628. Bianchi S, Bigazzi R, Campese VM: Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 34:973-995, 1999

629. Sarnak MJ, Coronado BE, Greene T, Wang S-R, Kusek JW, Beck GJ, Levey AS: Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002 (in press)

630. Keane WF: Proteinuria: Its clinical importance and role in progressive renal disease. Am J Kidney Dis 35:S97-S105, 2000 (suppl 1)

631. Culleton BF, Wilson PWF: Thrombogenic risk factors for cardiovascular disease in dialysis patients. Semin Dialysis 12:117-125, 1999

632. Massy ZA: Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. Nephrol Dial Transplant 15:81-91, 2000

633. Coresh J, Longenecker JC, Miller ER III: Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol 9:S24-S30, 1998 (suppl)

634. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12:218-225, 2001

635. Schillaci G, Reboldi G, Verdecchia P: High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 161:886-891, 2001

636. Pahor M, Shorr RI, Somes GW, Cushman WC, Ferrucci L, Bailey JE, Elam JT, Applegate WB: Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 158:1340-1345, 1998

637. Mann JF, Gerstein HC, Pogue J, Bosch JP, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001

638. Sechi LA, Zingaro L, De Carli S, Sechi G, Catena C, Falleti E, Dell’Anna E, Bartoli E: Increased serum lipoprotein(a) levels in patients with early renal failure. Ann Intern Med 129:457-461, 1998

639. Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E: Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. Kidney Int 56:1049-1057, 1999

640. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, Gardin JM: Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 279:585-592, 1998

641. Matts JP, Karnegis JN, Campos CT, Fitch LL, Johnson JW, Buchwald H: POSCH Group: Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. J Fam Pract 36:497-503, 1993

642. Hemmelgarn BR, Ghali WA, Quan H, Brant R, Norris CM, Taub KJ, Knudtson ML: Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis 37:64-72, 2001

643. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297-300, 1990

644. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37:1191-1200, 2001

645. Friedman PJ: Serum creatinine: An independent predictor of survival after stroke. J Intern Med 229:175-179, 1991

646. Wagener DK, Harris T, Madans JH: Proteinuria as a biomarker: Risk of subsequent morbidity and mortality. Environ Res 66:160-172, 1994

647. Ljungman S, Wikstrand J, Hartford M, Berglund G: Urinary albumin excretion—A predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 9:770-778, 1996

648. Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D: Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study. Am J Med 109:1-8, 2000

649. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033-2039, 1996

650. Agewall S, Wikstrand J, Ljungman S, Fagerberg B: Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 80:164-169, 1997

651. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 19:617-624, 1999

652. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 2:530-533, 1988

653. Kliger AS: Clinical practice guidelines and performance measures in ESRD. Am J Kidney Dis 32:S173-S176, 1998 (suppl 4)

654. Kliger AS, Haley WE: Clinical practice guidelines in end-stage renal disease: A strategy for implementation. J Am Soc Nephrol 10:872-877, 1999

655. Jaeschke R, Guyatt GH, Sackett DL: Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703-707, 1994

656. Laupacis A, Wells G, Richardson WS, Tugwell P: Users’ guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 272:234-237, 1994

657. Plan and operation of the third national health and nutrition examination survey, 1988–1994. Vital and Health Statistics, Series 1. 407. Bethesda, MD, National Center for Health Statistics, 1994

658. Ezzati T, Wakesberg J, Chu A: Sample design: Third national health and nutrition examination survey, 1988–1994. Vital and Health Statistics, Series 2. Bethesda, MD, National Center for Health Statistics, 1992

659. Kasiske BL, Keane WF: Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy, in Brenner BM, Rector FC Jr (eds): The Kidney. Philadelphia, PA, W.B. Saunders, 1996, pp 1137-1173

660. Coresh J, Toto RD, Kirk KA, Whelton PK, Massry SG, Jones C: Creatinine clearance as a measure of GFR in screenees for the African-American study of kidney disease and hypertension pilot study. Am J Kidney Dis 32:32-42, 1998

661. Coresh J, Astor B, McQuillan G: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002 (in press)

662. Chavers BM, Simonson J, Michael AF: A solid-phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 25:576-578, 1984

663. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997

664. Stata Statistical Software: Release 6.0. College Station, TX, Stata Corp, 1999

665. Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33:27-39, 1980

666. Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65, 1985

667. Gotch F, Keen ML: Care of the Patient on Dialysis: Introduction to Dialysis. New York, NY, Churchill Livingston, 1991, pp 101-179

© 2002 National Kidney Foundation, Inc